New guidance from the IDSA for treating three of the most common drug-resistant pathogens was published today on the IDSA website.
New guidance from the IDSA for treating three of the most common drug-resistant pathogens was published today on the IDSA website.
IDSA supports the FDA and CDC decision to expand eligibility for COVID-19 vaccine boosters to include everyone age 18 and older.
IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Sens. Tammy Baldwin (D-WI) and Susan Collins (R-ME).
IDSA, the nation’s leading infectious diseases professional society, recognizes the distinguished clinicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA.
IDSA supports COVID-19 vaccine mandates announced by the Occupational Safety and Health Administration for large private employers and the Centers for Medicare and Medicaid Services for employees at Medicare and Medicaid-participating health care facilities.
In recognition of the importance of inclusion, diversity, access and equity as long-term priorities and core values for IDSA, the Society’s Board of Directors recently approved the creation of a permanent IDA&E Committee.
The rise of more transmissible variants of SARS-CoV-2 has spurred growing interest in harnessing information about the genetic sequences of these variants to help treat patients.
To date, 6 million children have been diagnosed with COVID-19. The more than 28 million children who will be eligible to be vaccinated against COVID-19 with this authorization comprise a larger portion of the population than the already eligible 12-17-year-old cohort.
The Infectious Diseases Society of America strongly supports the CDC’s recommendation that unvaccinated people previously infected with the virus that causes COVID-19 get vaccinated as soon as possible after they have fully recovered.
The Infectious Diseases Society of America supports the CDC Advisory Committee on Immunization Practice’s unanimous recommendation to allow “mix-and-match”—or heterologous—COVID-19 booster shots for at-risk populations.
IDSA and HIVMA applaud the bipartisan introduction of the Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act by Reps. Lori Trahan (D-MA) and David McKinley (R-WV), H.R. 5602, and its inclusion in an Oct. 26 Energy and Commerce Health Subcommittee hearing.
In legal rulings issued on Sept. 1 and Sept. 20, a federal judge in Texas dismissed all claims a group of Lyme disease patients had brought against the Infectious Diseases Society of America.